2024-519533-38-00招募中1 期
A study to see the effect of NNC0194-0499 alone or in combination with semaglutide on blood sugar control in people living with type 1 diabetes.
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 96
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
EU Submission Hub
Scientific
Novo Nordisk A/S
研究点 (1)
Loading locations...
相似试验
已完成
1 期
A research study on the effects of NNC0537-1482 in healthy individuals when injected under the skin.Heart Failure2024-514431-18-00Novo Nordisk A/S56
已完成
1 期
A research study looking at how the compound NNC0194-0499 works with birth control pills in women not able to bear children.2023-503595-24-00Novo Nordisk A/S30
已完成
1 期
A study to assess the effect of CC-95251 alone and in combination with anti-cancer drugs in subjects with Acute Myeloid Leukemia and Myelodysplastic Syndromes2023-506117-22-00Celgene Corp., Celgene Corp.153
已完成
1 期
A Phase 1 Randomized Study to Evaluate the Effect of Food on the Bioavailability of BMS-986158 in Participants with Advanced Solid Tumors.2023-506661-65-00Bristol-Myers Squibb Services Unlimited Company40
进行中（未招募）
1 期
Research study on whether a combination of 2 medicines (NNC0194-0499 and semaglutide) works in people with non-alcoholic steatohepatitis (NASH)on-alcoholic steatohepatitisMedDRA version: 24.1Level: PTClassification code 10053219Term: Non-alcoholic steatohepatitisSystem Organ Class: 10019805 - Hepatobiliary disordersEUCTR2020-003566-39-FRovo Nordisk A/S672